SteelPeak Wealth’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,106
| Closed | -$188K | – | 530 |
|
|
2024
Q4 | $188K | Sell |
16,106
-3,000
| -16% | -$35K | 0.01% | 458 |
|
|
2024
Q3 | $393K | Buy |
+19,106
| New | +$393K | 0.02% | 339 |
|
|
2024
Q2 | – | Sell |
-8,309
| Closed | -$229K | – | 483 |
|
|
2024
Q1 | $229K | Buy |
+8,309
| New | +$229K | 0.01% | 383 |
|
|
2023
Q4 | – | Sell |
-8,308
| Closed | -$263K | – | 427 |
|
|
2023
Q3 | $263K | Sell |
8,308
-1,851
| -18% | -$58.5K | 0.02% | 337 |
|
|
2023
Q2 | $414K | Sell |
10,159
-3,467
| -25% | -$141K | 0.02% | 258 |
|
|
2023
Q1 | $508K | Buy |
13,626
+4,511
| +49% | +$168K | 0.03% | 236 |
|
|
2022
Q4 | $318K | Sell |
9,115
-3,997
| -30% | -$139K | 0.02% | 296 |
|
|
2022
Q3 | $734K | Sell |
13,112
-1,605
| -11% | -$89.8K | 0.05% | 188 |
|
|
2022
Q2 | $762K | Buy |
14,717
+362
| +3% | +$18.7K | 0.05% | 199 |
|
|
2022
Q1 | $1.04M | Buy |
14,355
+6,550
| +84% | +$476K | 0.06% | 175 |
|
|
2021
Q4 | $923K | Sell |
7,805
-2,179
| -22% | -$258K | 0.05% | 177 |
|
|
2021
Q3 | $1.34M | Sell |
9,984
-1,537
| -13% | -$206K | 0.09% | 133 |
|
|
2021
Q2 | $1.87M | Buy |
11,521
+1,080
| +10% | +$175K | 0.13% | 114 |
|
|
2021
Q1 | $838K | Buy |
10,441
+4,038
| +63% | +$324K | 0.07% | 170 |
|
|
2020
Q4 | $348K | Buy |
+6,403
| New | +$348K | 0.03% | 245 |
|